Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 598 results for "cadila pharmaceutical"

Zydus Cadila and Takeda partner to develop vaccine for Chikungunya virus
Pharmaceutical Technology

Zydus and Takeda collaborates for chikungunya vaccine

Share Tweet Share Share Share Zydus Cadila and Takeda Pharmaceutical have entered into partnership to develop the first vaccine to treat chikungunya virus infection. The broad-based agreement includes early stage development ... EHealth Magazine, 3 days ago
[x]  
India Infoline

Zydus, Takeda partner to develop & market chikungunya vaccine

Zydus Cadila, an innovation driven global healthcare provider and Takeda Pharmaceutical Company Limited, (Takeda), announced a partnership to tackle chikungunya, an emerging infectious disease. The chikungunya virus is most often spread to people by ...
 PharmaBiz4 days ago Cadila Healthcare rises 1.3% after partnering with Takeda Pharma  India Infoline4 days ago Zydus and Takeda enter into partnership to address emerging infectious diseases  India Infoline5 days ago Zydus Cadila enters into partnership with Takeda  HT Syndication5 days ago
[x]  
Business Standard India

Cadila Healthcare gains on EIR for Ahmedabad facility

Cadila Healthcare surged 4% to Rs 391 on the BSE after the pharmaceutical company said that its oral solid dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug ...
 Business Standard India3 weeks ago Cadila's Ahmedabad drug manufacturing unit gets EIR from USFDA  HT Syndication3 weeks ago Cadila Healthcare gains after getting EIR from USFDA for Ahmedabad facility  Capital Market3 weeks ago Cadila's Changodar unit gets Establishment Inspection report from USFDA  HT Syndication1 month ago
The Telegraph

Quartet picked to buy Teva drugs

Four Indian companies - Cipla, Aurobindo Pharma, Dr Reddy's and Zydus Cadila - are among the 11 companies to buy 79 existing and future drugs of Teva Pharmaceutical Industries. The divestment is one of the conditions set by the US Federal Trade Commission ...
 The Telegraph1 month ago Aurobindo, Intas bid for Teva's products in Europe  VC Circle3 weeks ago Cipla, Aurobindo Pharma acquire products divested by Teva in US  Livemint.com1 month ago Cipla, Aurobindo Pharma to acquire drugs from Teva  VC Circle1 month ago
India Infoline

Here's why Canara Bank, pharma cos, Texmaco Rail are in news

Some of the stocks that should be on your radar are: Axis Bank, NCC, Canara Bank, State Bank of Mysore, Cadila Healthcare, Cipla, PNC Infratech, Sun Pharma Advanced Research Company, Sun Pharmaceutical Industries, Dr Reddys Laboratories, Texmaco Rail and ...
 Money Control2 months ago Buzzing stocks: Indian Bank zooms, Bata India drops, Cadila Healthcare up  India Infoline1 month ago Net worth of 30 top Indian pharma cos move up by 20% in 2015-16  PharmaBiz2 months ago Buzzing stocks: Castrol India zooms, Jubilant FoodWorks tanks, Den Network up  India Infoline4 days ago
India Infoline

Cadila Healthcare Ltd updates on selling of Asacol HD

Posted On: 2016-07-17 19:58:29 Cadila Healthcare Ltd's US based 100% subsidiary company Zydus Pharmaceuticals (USA) Inc. (Zydus) will begin informing on July 12, 2016 its customers that Zydus will start selling an authorized generic of Asacol HD ...
 Equity Bulls2 months ago Buzzing stocks: Cadila Healthcare jumps, Bata India drops, Punj Lloyd up  India Infoline1 month ago Zydus to sell Asacol HD's generic in US market  Business Standard2 months ago

Cadila HC Q1 PAT seen down by 8.8% at Rs 354.6 cr: Religare

Religare Research has come out with its first quarter (April-June) earnings estimates for the India Pharmaceuticals sector. The brokerage house expects Cadila HC to report a degrowth of 8.8 percent quarter-on-quarter (up of 0.3 percent year-on-year) ...
 Moneycontrol.com2 months ago

Cadila eyes growth opportunity in US, LatAm formulation mkts

Pharma firm Cadila Healthcare sees big growth opportunity in US and Latin American formulation markets and plans to enhance share in the US generics market by launching complex, oral solids and formulations. "Going forward, the company's focus will continue ...
 DNA2 months ago

6 Indian pharma cos ink pact with MPP

Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs. A total of nine new ...
 Deccan Herald2 months ago 6 Indian pharma cos ink licensing pact with UN-backed MPP [Seven Days (United Arab Emirates)]  Pharmacy Choice2 months ago
Silicon India

Zydus Cadila in Association with Japan's Takeda Pharma to Develop Chikungunya Vaccine

Zydus Cadila joins hand with Japan's Takeda Pharmaceutical to prepare vaccine that will provide immunity against chikungunya. The contract between the companies includes developing the vaccine from the scratch till the final commercialization of the vaccine.
 Silicon India3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less